Pyxus inks agreement with Turning Point to initiate PMTA submission
Category: #business  | By Mateen Dalal  | Date: 2020-02-07 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Pyxus inks agreement with Turning Point to initiate PMTA submission

Pyxus International, Inc., one of the leading value-added agricultural companies in the world, has reportedly collaborated with Turning Point Brands, a leading company in OTP (Other Tobacco Products) and adult consumer alternatives.

Sources cite that the two companies have agreed to share certain testing data and science-based research to form the foundation of some of their respective PMTAs (Premarket Tobacco Product Applications) before being submitted to U.S. FDA (Food and Drug Administration).

According to reports, Turning Point Brands has inked a supply agreement for its house brands of e-liquids, thereby extending its existing collaboration with Pyxus' joint venture, Purilum, LLC, a manufacturer of high-quality e-liquids, finished bottles, and flavor concentrates products.

Apparently, all tobacco products modified or introduced after Feb. 15, 2007, require premarket permission by the FDA to be commercially marketed in the US. Pursuant to the FDA guidance, all PMTAs are due by 12 May 2020.

Reportedly, both companies will share several costs and key data related to extensive studies conducted to support their PMTAs filings. Additionally, Purilum presently offers the flavor formulations for a few of TPB's innovative products.

Pieter Sikkel, President, CEO and Chairman of Pyxus, said that the company needs likeminded, reputable partners to meet the stringent requirements of the U.S. FDA.

He added that Turning Point Brands, which presently has a strong relationship with the company’s joint venture Purilum, has constantly shown their commitment to quality and compliance. The company is pleased to partner with them to benefit respective PMTAs.

Graham Purdy, COO of Turning Point Brands, said that Purilum has garnered a reputation for excellence in e-liquid production and flavor formulation. Moreover, the consistency and quality of their products are exemplary, and the company is excited to continue to work with them over the next decades.

Both Turning Point Brands and Pyxus anticipate the filing of their respective PMTAs before the May filing deadline.

Source Credit - https://www.prnewswire.com/news-releases/pyxus-signs-agreement-with-turning-point-brands-initiating-pmta-project-collaboration-300999171.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

IMCD aims expansion in Bangladesh with a new office & laboratory launch

IMCD aims expansion in Bangladesh with a new office & laboratory launch

By Mateen Dalal

IMCD, a global leader in the formulation and distribution of speciality chemicals and ingredients, has recently announced that it is opening a Dhaka office and Food & Nutrition Application Laboratory to embrace its proficiency and expand its foot...

Celcom and Digi unite to drive digitalization for consumers, businesses

Celcom and Digi unite to drive digitalization for consumers, businesses

By Mateen Dalal

Axiata Group Bhd or Axiata and Digi.Com Bhd are anticipating the potential of their proposed merger company, which is expected to be known as Celcom Digi Bhd, for solidifying the capacity to accelerate digitization for businesses, consumers, and the ...

QRCS & WHO offer mental health support to Syrians affected by COVID-19

QRCS & WHO offer mental health support to Syrians affected by COVID-19

By Mateen Dalal

The representation office of the Qatar Red Crescent Society (QRCS) housed in Gaziantep, Turkiye will reportedly deploy three mobile mental health clinics in Syria. Backed by the funding from the World Health Organization (WHO), QRCS will ensure th...